Polartechnics moves into Pakistan
Monday, 09 March, 2009
Sydney’s Polartechnics has received another international order for its TruScreen cervical cancer screening technology, this time with Pakistan.
The Pakistani Government has initially ordered 100 units but expects to order more in the future.
TruScreen is a point of care detection device for cervical cancer. Cervical cancer is the fourth most common cancer in Pakistan, which has a female population of more than 85 million.
Last month, Polartechnics signed distribution agreements with major medical companies in Indonesia, Thailand, the Philippines and Sri Lanka.
Polartechnics also produces a self-administered HPV test called CerviScreen under a joint venture with Genera BioSystems and Gribbles Pathology.
Breakthrough drug prevents long COVID symptoms in mice
Mice treated with the antiviral compound were protected from long-term brain and lung dysfunction...
Antibiotics hinder vaccine response in infants
Infants who received antibiotics in the first few weeks of life had significantly lower levels of...
Colossal announces 'de-extinction' of the dire wolf
Colossal Biosciences has announced what it describes as the rebirth of the dire wolf, which would...